Li X - Search Results

1

High-throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion.

Song Z, Xu C, Pu X, Zhu Y, Wang W, Li X, Gao Y, Zhu W, He Y, Wu L, Mao L, Chen L, Chen M. Song Z, et al. Among authors: li x. Cancer Commun (Lond). 2021 Feb;41(2):192-196. doi: 10.1002/cac2.12133. Epub 2021 Jan 16. Cancer Commun (Lond). 2021. PMID: 33452864 Free PMC article. No abstract available.

2

ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib.

Xu S, Wang W, Xu C, Li X, Ye J, Zhu Y, Ge T. Xu S, et al. Among authors: li x. BMC Cancer. 2019 Aug 5;19(1):769. doi: 10.1186/s12885-019-5948-y. BMC Cancer. 2019. PMID: 31382924 Free PMC article.

3

Identification of a Novel Icotinib-Sensitive EGFR-SEPTIN14 Fusion Variant in Lung Adenocarcinoma by Next-Generation Sequencing.

Zhu YC, Wang WX, Li XL, Xu CW, Chen G, Zhuang W, Lv T, Song Y. Zhu YC, et al. J Thorac Oncol. 2019 Aug;14(8):e181-e183. doi: 10.1016/j.jtho.2019.03.031. J Thorac Oncol. 2019. PMID: 31345345 Free article. No abstract available.

4

Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors.

Chen HF, Wang WX, Li XL, Xu CW, Du KQ, Zhu YC, Fang MY. Chen HF, et al. J Thorac Oncol. 2019 Oct;14(10):e217-e219. doi: 10.1016/j.jtho.2019.04.032. J Thorac Oncol. 2019. PMID: 31558230 Free article. No abstract available.

5

Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer.

Li J, Li X, Wang W, Shao Y, Zhang Y, Song Z. Li J, et al. Among authors: li x. Transl Oncol. 2020 Aug;13(8):100784. doi: 10.1016/j.tranon.2020.100784. Epub 2020 May 16. Transl Oncol. 2020. PMID: 32428850 Free PMC article.

6

Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib.

Zhu YC, Wan B, Wu LX, Li XL, Wang WX, Xu CW, Zhuang W, Wei JG, Du KQ. Zhu YC, et al. Transl Cancer Res. 2019 Aug;8(4):1630-1634. doi: 10.21037/tcr.2019.06.23. Transl Cancer Res. 2019. PMID: 35116907 Free PMC article.

7

A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib.

Chen D, Li XL, Wu B, Zheng XB, Wang WX, Chen HF, Dong YY, Xu CW, Fang MY. Chen D, et al. Front Oncol. 2020 Jun 16;10:867. doi: 10.3389/fonc.2020.00867. eCollection 2020. Front Oncol. 2020. PMID: 32656077 Free PMC article.

8

FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib.

Ying X, Tu J, Wang W, Li X, Xu C, Ji J. Ying X, et al. Among authors: li x. Onco Targets Ther. 2019 Nov 6;12:9303-9307. doi: 10.2147/OTT.S218796. eCollection 2019. Onco Targets Ther. 2019. PMID: 31807010 Free PMC article.

9

Molecular Analysis of Oncogenic Mutations in Resected Margins by Next-Generation Sequencing Predicts Relapse in Non-Small Cell Lung Cancer Patients.

Wei W, Li X, Song M, Wang C. Wei W, et al. Among authors: li x. Onco Targets Ther. 2020 Sep 25;13:9525-9531. doi: 10.2147/OTT.S257991. eCollection 2020. Onco Targets Ther. 2020. PMID: 33061436 Free PMC article.

10

A narrative review of sleep and breast cancer: from epidemiology to mechanisms.

Zhang B, Tang M, Li X. Zhang B, et al. Among authors: li x. Cancer Causes Control. 2024 Dec 28. doi: 10.1007/s10552-024-01951-8. Online ahead of print. Cancer Causes Control. 2024. PMID: 39731679 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,467 results

Search Page

Filters